UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 by Intellectual Property Watch 2 Comments The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at “exorbitant” rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an “appropriate” return on taxpayer investments.
Japan Patent Office Decides “TE’ CON MIEL” (Tea With Honey) Is Distinctive In Relation To Tea 20/02/2018 by Guest contributor for Intellectual Property Watch Leave a Comment In a recent trademark opposition, the Opposition Board of the Japan Patent Office (JPO) decided to overrule the opposition against TM Registration no. 5951823 for word mark “TÉ CON MIEL” designating tea in class 30 due to distinctiveness of the mark among relevant Japanese consumers.
Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 by William New, Intellectual Property Watch Leave a Comment The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies’ IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a “tirade” and “self-serving”.
Republic Day Of India Celebration In Geneva: Sounds, Sights, Tastes – And History 30/01/2018 by William New, Intellectual Property Watch 1 Comment Friends and followers of the nation and culture of India gathered in Geneva this week to celebrate India’s Republic Day, with a ceremony and feast held in the halls of the UN World Intellectual Property Organization. Among the many achievements and areas of growth mentioned of the rising economy was its prowess in generic medicines production.
JPO Refused To Register Wordmark “ROMEO GIGLI” Due To Lack Of Consent From Italian Fashion Designer 29/01/2018 by Guest contributor for Intellectual Property Watch Leave a Comment In a recent decision, the Appeal Board of Japan Patent Office (JPO) refused to register trademark application no. 2015- 100245 for a red-colored word mark “ROMEO GIGLI” in gothic script (see below) designating goods of Class 24 and 25 on the grounds that applicant failed to obtain a consent from Italian fashion designer, Romeo Gigli, based on Article 4(1)(viii) of the Trademark Law, writes Masaki Mikami.
Japan Patent Office Invalidates The Word Mark “Bord’or” In Relation To Bordeaux Wines 12/01/2018 by Guest contributor for Intellectual Property Watch 1 Comment In a decision in an invalidation trial jointly claimed by INSTITUT NATIONAL DE L’ORIGINE ET DE LA QUALITE and CONSEIL INTERPROFESSIONNEL DU VIN DE BORDEAUX, the Invalidation Board of Japan Patent Office (JPO) ordered the invalidation of trademark registration no. 5737079 for a word mark “Bord’or” in script fonts (see below) in violation of Article 4(1)(vii) of the Trademark Law, writes Masaki Mikami.
Starbucks Trademark Dispute Brewing Over Bull Pulu Tapioca Logo 18/12/2017 by Guest contributor for Intellectual Property Watch 1 Comment The Japan Patent Office (JPO) has rejected an opposition from Starbucks to trademark registration no. 5897739 for the green-and white “BULL PULU TAPIOCA” concentric circle logo with a puppy white bull dog in the center, writes Masaki Mikami.
Analysis: As Biosimilar Of Key Cancer Drug Spreads, Where Is The Price Reduction? 11/12/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.
Access To Affordable Healthcare: A Global Wake-Up Call Fosters Coalition Of The Like-Minded 27/11/2017 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment NEW DELHI — Few topics in the global health agenda are as contentious as access to affordable medicines and medical care, and expectedly, divergent views permeated the discussions at a high-level conference in New Delhi, India last week. But if there is one thing that the three-day meet made amply clear, it was this: access to affordable healthcare has emerged as a global problem, and an emerging coalition of the like-minded, cutting across the developed and developing countries, is determined to have their voices heard in international policy circles on the issue.
WIPO GREEN Seeks Consultants For Tech Deals In Asia-Pacific 20/11/2017 by Intellectual Property Watch Leave a Comment The World Intellectual Property Organization program on intellectual property and environmental technology is looking for consultants to catalyze green tech transactions in the Asia-Pacific region.